Pending results of the California Practice Standards and Jurisprudence Exam (CPJE) have been invalidated for 1400 applicants that recently took the test, due to a cheating issue.
The open-label Phase 2 trial looked to expand treatment for patients with newly diagnosed and persistent immune thrombocytopenia.
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) agreed on a positive opinion for AbbVie’s upadacitinib (RINVOQ), according to the company.
Top news of the week from Specialty Skidki-na-vse.
Top news of the day from across the health care landscape.
After participating in a sleep-education program, 41% of participants who survived cancer had their insomnia successfully treated.
Nine widely-used medications have experienced substantial price growth since 2016, adding $5.1 billion to overall drug spending.
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Abrocitinib showed improvements in skin clearance and itch relief in patients aged 12 years and older with moderate-to-severe atopic dermatitis.
A new Health Trends study released by Quest Diagnostics has highlighted many physicians' overconfidence in their ability to identify and treat substance misuse, as well as concerns that the drug gabapentin is increasingly being misused.
Glenmark Pharmaceuticals has received FDA approval for abiraterone acetate tablets USP, 250 mg, a generic of Janssen's Zytiga tablets, 250 mg.1
Which Halloween costumes are generating the most buzz this year?
Baloxavir marboxil (Xofluza, Genentech) is the first antiviral medication indicated for patients at high risk of developing influenza-related complications.
Although the demand for pharmacists is expected to increase in a variety of health care settings, the employment of pharmacists in this industry is projected to decline overall in the next 10 years.
Study suggests that blocking a signaling pathway that includes the inflammatory factor CXCL10-CXCR3 may prevent brain metastasis.
+ Load More